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Abstract
Background: Public concerns are commonly expressed about widening health gaps. This cohort study examines
variations and trends in cancer survival by socio-economic disadvantage, geographical remoteness and country of
birth in an Australian population over a 30-year period.
Methods: Data for cases diagnosed in New South Wales (NSW) in 1980–2008 (n = 651,245) were extracted from
the population-based NSW Cancer Registry. Competing risk regression models, using the Fine & Gray method, were
used for comparative analyses to estimate sub-hazard ratios (SHR) with 95% confidence intervals (CI) among people
diagnosed with cancer.
Results: Increased risk of cancer death was associated with living in the most socio-economically disadvantaged
areas compared with the least disadvantaged areas (SHR 1.15, 95% CI 1.13–1.17), and in outer regional/remote areas
compared with major cities (SHR 1.05, 95% CI 1.03–1.06). People born outside Australia had a similar or lower risk of
cancer death than Australian-born (SHR 0.99, 95% CI 0.98–1.01 and SHR 0.91, 95% CI 0.90–0.92 for people born in
other English and non-English speaking countries, respectively). An increasing comparative risk of cancer death was
observed over time when comparing the most with the least socio-economically disadvantaged areas (SHR 1.07,
95% CI 1.04–1.10 for 1980–1989; SHR 1.14, 95% CI 1.12–1.17 for 1990–1999; and SHR 1.24, 95% CI 1.21–1.27 for
2000–2008; p < 0.001 for interaction between disadvantage quintile and year of diagnosis).
Conclusions: There is a widening gap in comparative risk of cancer death by level of socio-economic disadvantage
that warrants a policy response and further examination of reasons behind these disparities.
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Background
Socio-economic differences in cancer survival have been
reported in many countries [1–6], including in Australia
for cancers overall [7, 8] and specific cancer sites [7, 9, 10].
However, it has been unclear whether survival disparities
are narrowing or widening [3, 5, 10–14]. In the United
Kingdom (UK), socio-economic cancer survival inequalities
persisted or widened over 1986–2001 [13]. By 2006 in the
UK, the deprivation gap in 1-year survival had narrowed
slightly with survival inequalities remaining wide [3]. A
Japanese study reported overall improving cancer survival
without significant widening of inequalities over 1993–
2004 [5], whereas a study from New Zealand found an in-
crease in cancer survival disparities across income groups
over 1991–2004 [14]. A recent Australian study reported
that socio-economic cancer survival disparities have
remained for several cancer sites over 1996–2008, despite
overall increases in cancer survival [10]. These examples
indicate a need to reliably identify existing and changing
cancer survival disparities to inform health-service
provision.
In Australia, apart from people of low socio-economic
status, potentially disadvantaged population groups
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include residents of remote/rural areas and people born
overseas [15]. Australians living in remote and rural areas
generally have poorer cancer survival than people living in
metropolitan areas [11, 16, 17]. A recent Australian study
reported a widening gap by residential remoteness in
breast cancer survival over 1987–2007 [11]. Australia has
a large immigrant population comprising 28% of the
population (6.6 million in 2014) [18]. Data for 1981–2007
indicated that migrants in Australia generally have lower
cancer mortality than the Australian-born although there
were differences between migrant groups [19]. Large-
scale, whole-population studies examining cancer survival
differences between migrant groups in Australia are
lacking.
Various methods have been used to examine cancer
survival disparities, however, the impact of competing
risk events has been rarely acknowledged. Competing
risk regression modelling takes directly into account the
effects of competing risk events which are censored/
ignored in cause-specific survival models [20]. If these
competing events co-vary with the outcome or factors
of interest, not accounting for competing events could
lead to biased estimates of risk [21]. Acknowledging
competing risk events is especially important when
studying older people with multiple co-morbidities
and higher mortality rates from other causes during
long follow-up periods, such as for people with cancer
[22]. One Australian study reported cancer patients
having 50% higher risk of death due to non-cancer
causes compared with the general population [23].
Results of competing risk regression may be especially
relevant for guiding resource allocation in the presence
of multiple competing risk events [20, 21]. The present
study examines variations and trends in cancer survival
by socio-economic disadvantage, geographical remote-
ness and country of birth in New South Wales (NSW)
over almost three decades (1980–2008), taking into ac-
count competing causes of death.
Methods
Study design, setting and data sources
NSW is the most populous state in Australia with an esti-
mated resident population of seven million people in 2008
(33% of the Australian population) [24]. Population-based
New South Wales Cancer Registry (NSW CR) data were
used for this study. Cases of primary invasive cancer diag-
nosed in NSW residents have been reported to the NSW
CR since 1972 (excluding non-melanoma skin cancers).
All notifications relating to a particular cancer are linked
to a single person and if the same person is diagnosed
with another primary cancer in a different site, that cancer
counts as a second case. NSW CR data include demo-
graphic information, cancer diagnosis and death data, and
residential address at time of diagnosis. The NSW Registry
of Births, Deaths and Marriages, the Australian Bureau of
Statistics (ABS) and the National Death Index (NDI)
provide death data including deaths due to cancer and
from other (non-specified) causes. Death processing is
very complete in NSW and cause of death information
is well ascertained in the NSW CR [25].
This cohort study included cancer cases diagnosed be-
tween January 1980 and December 2008, apart from: [1]
those with central nervous or lymphohaematopoietic tu-
mours, excluded due to high proportions of missing values
or non-applicable summary stage information (n = 76,912);
[2] those with only death certificate information available
(DCO cases) and those cancers found only at post-mortem
(n = 12,006); and [3] those with missing information on
socio-economic disadvantage (n = 2171).
Approval for the study was obtained from the NSW
Population and Health Services Research Ethics Com-
mittee (NSW PHSREC 2012 07410). Data analysed for
this paper are not able to be shared on any publicly
available repository due to NSW privacy laws.
Measures
Study variables
Residential remoteness was indicated by remoteness areas
(RAs) based on the Accessibility/Remoteness Index of
Australia (ARIA+) and categorised as major cities (refer-
ence category), inner regional and outer regional/remote
areas [26]. ARIA+ indices are derived from measures of
physical road distance between populated localities and
the nearest urban centre. RA categories were determined
by aggregating remoteness allocations of corresponding
Census Collection Districts (CDs) for cases diagnosed in
2000–2008. For cases diagnosed in 1980–1999, Statistical
Local Area (SLA) population based correspondence was
used to calculate RAs [27].
The Australian Bureau of Statistics (ABS) has created
four Socio-Economic Indexes for Areas (SEIFAs) [28].
This study utilized the Index of Relative Socio-Economic
Disadvantage (IRSD) which summarises information about
the socio-economic conditions of people and households
in a specified area. For this study, the IRSD was based on
CD of residence at the time of diagnosis using the CD
boundaries of the most recent ABS Census. CDs were the
smallest geographic units with SEIFA information available.
In the 2006 Census, they included approximately 250
households in urban areas and far fewer households in
rural areas [28]. Socio-economic disadvantage was cate-
gorised into equal-population quintiles (1: least disadvan-
taged (reference category) - 5: most disadvantaged).
For the purposes of this study, country of birth was
categorised into Australia (reference category), other pre-
dominantly English speaking, predominantly non-English
speaking countries and unknown (no country-of-birth in-
formation available from the NSW CR). Other English
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speaking countries include New Zealand, the United
Kingdom, Ireland, the United States of America, Canada,
and South Africa, based on the ABS categorisation [29].
Variables for adjustment
Age in years at the time of cancer diagnosis was cate-
gorised as <65, 65–79 and ≥80 years for descriptive ana-
lyses, and as 0–39, 40–49, 50–59, 60–64, 65–69, 70–74,
75–79, 80–84 and 85+ years in regression models.
The NSW CR is the only Australian cancer registry
that has recorded summary stage (extent of disease) for
all solid malignant tumours since its inception [30].
Summary stage is defined as the highest degree of spread
based on all diagnostic and therapeutic information
available to the NSW CR up to four months after the
cancer diagnosis, in accordance with international guide-
lines used by cancer registries worldwide [30]. Summary
stage was categorised as localised, regional, distant or
unknown.
Cancer site classification was according to the Inter-
national Classification of Diseases Oncology (ICD-O-3)
[31]. Following an ICD-classification change to ICD-O-3
in 2003, data for earlier years were re-mapped from the
previous ICD-9 classification, and recoded where neces-
sary, to comply with ICD-O-3 standards. Cases with
central nervous or lymphohaematopoietic tumours were
excluded (C70-C72, M959-M973, M976, M980-M994,
M9963, M9987, C42 or C77 with M974, M975, M995-
M996 (excluding M9963)). Remaining cancer sites
were classified as follows: stomach (C16), colon/rectum
(C18,C19-C21), liver (C22), pancreas (C25), lung (C33,C34),
melanoma of the skin (C44 with M872-M879), breast (C50),
cervix (C53), uterus (C54,C55), prostate (C61), kidney (C64-
C66,C68), bladder (C67), ill-defined, unspecified & rare sites
(C26,C39,C42,C48,C76,C80), and remaining malignant can-
cer sites (‘other cancers’).
Other variables for adjustment included sex and diag-
nostic period (1980–1989, 1990–1999 and 2000–2008).
Statistical analyses
Competing risk regression models using the Fine & Gray
approach were used to examine hazard of death due to
cancer [32] using Stata stcrreg command [33]. Compet-
ing risk regression models the subhazard function of an
event of interest in the presence of competing events
(also known as the cumulative incidence function). In
this study, we were interested in cumulative incidence of
the cancer death in the presence of other causes of
deaths. Death from the incident cancer was the outcome
of interest, and deaths from other causes were regarded
as competing events. Cases were followed from the date
of cancer diagnosis to death or to 1 January 2009, which
ever occurred first.
Multivariable models included the study variables (re-
moteness, socio-economic disadvantage quintile and
country of birth), and were adjusted for sex, age and
diagnostic period (Model 1); with further adjustment for
cancer site (Model 2); and for summary stage (Model 3).
Trends over time were examined using interaction terms
and period-stratified analyses. Wald’s chi-square test was
used to examine the overall significance of interactions
between categorical study variables and year of diagnosis,
expressed as a continuous variable. Cancer site-specific
analyses were conducted for lung, colon/rectum, breast,
prostate, melanoma, stomach, cervix and liver cancers.
These sites were selected because they represent high-
burden cancers and/or cancers considered likely to be
affected by social disparities [2, 6–8].
Results were presented as sub-hazard ratios (SHRs)
with 95% confidence intervals (CIs). Proportional hazards
assumptions were examined using -ln[−ln(survival)]
curves. We also conducted sensitivity analyses exclud-
ing cases with unknown summary stage and cases with
unknown country of birth. All analyses were performed
using Stata Statistical Software: Release 14 (College
Station, TX: StataCorp LP, 2015).
Results
A total of 651,245 cases with a mean follow-up of
5.5 years were included in the study. Of these, 358,011
(55.0%) were males, 281,795 (43.3%) were aged <65 years
at diagnosis, and 281,783 (43.3%) were diagnosed with a
localised cancer (Table 1). Most people lived in major
cities (n = 458,455, 70.4%) and were born in Australia
(n = 444,879, 68.3%). Fewer people lived in the least
socio-economically disadvantaged areas than in the most
disadvantaged areas (n = 115,352, 17.7% in quintile 1 vs.
n = 144,534, 22.2% in quintile 5).
Overall survival analyses
After adjusting for age, sex, diagnostic period, summary
stage, cancer site and other study variables, people living
in outer regional/remote areas had a slightly increased
risk of cancer death compared with people living in major
cities (SHR 1.05, 95% CI 1.03–1.06) (Model 3, Table 2).
Compared with cases living in the least socio-economically
disadvantaged areas, those living in all other SEIFA quin-
tiles had an increased risk of cancer death, with the highest
risk elevation observed for the most disadvantaged areas
(SHR 1.15, 95% CI 1.13–1.17). People born in other Eng-
lish speaking countries had a similar risk (SHR 0.99,
95% CI 0.98–1.01), and people born in non-English
speaking countries had a slightly lower risk of cancer
death than the Australian-born (SHR 0.91, 95% CI
0.90–0.92). Results were similar after excluding cases
with unknown summary stage (data not shown).
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Interactions between diagnostic year and study vari-
ables indicated significant time variations in relation to
socio-economic disadvantage quintiles (p < 0.001) but
not in relation to remoteness (p = 0.511) or country of
birth (p = 0.078) when unknown country of birth was
excluded.
Period-stratified analyses indicated largely constant
trends over time in risk of cancer death by remoteness
and country of birth (Table 3). However, when compar-
ing the most with the least socio-economically disadvan-
taged areas, disparities in risk of death from cancer
increased over time (SHR 1.07, 95% CI 1.04–1.10 for
1980–1989; SHR 1.14, 95% CI 1.12–1.17 for 1990–1999;
and SHR 1.24, 95% CI 1.21–1.27 for 2000–2008) (Table 3,
Fig. 1).
Cancer site-specific survival analyses
Compared with major cities, living in outer regional/
remote areas was generally associated with a slightly
increased risk of cancer death, with the highest eleva-
tions observed for stomach (SHR 1.15, 95% CI 1.07–
1.24), colon/rectum (SHR 1.12, 95% CI 1.08–1.17), cer-
vix (SHR 1.24, 95% CI 1.07–1.43) and prostate cancers
(SHR 1.10, 95% CI 1.05–1.16) (Table 4).
Living in the most socio-economically disadvantaged
areas compared with the least disadvantaged areas was
generally associated with higher risk of cancer death,
with the most pronounced disparities observed for liver
cancer (SHR 1.22, 95% CI 1.11–1.34) and melanoma
(SHR 1.25, 95% CI 1.16–1.34); followed by prostate
(SHR 1.16, 95% CI 1.11–1.22), lung (SHR 1.15, 95% CI
1.12–1.18), colon/rectum (SHR 1.14, 95% CI 1.10–1.18),
and breast cancer (SHR 1.14, 95% CI 1.08–1.19).
People born in non-English speaking countries generally
had a lower risk of cancer death than the Australian-born,
with the exception of melanoma (SHR 1.26, 95% CI 1.14–
1.39) and breast cancer (SHR 0.98, 95% CI 0.94–1.02, i.e.,
no statistically significant difference). People born in other
English speaking countries had similar risks of cancer
death to the Australian-born, with the exception of a
lower risk for cervix cancer (SHR 0.83, 95% CI 0.73–0.94).
Results remained largely similar when cases with un-
known summary stage were excluded, with the following
exceptions:
Liver cancer
– SHR 0.95, 95% CI 0.85–1.07 for people living in
inner regional areas
– SHR 0.83, 95% CI 0.72–0.96 for people born in
other English speaking countries
Breast cancer
– SHR 0.93, 95% CI 0.89–0.97 for people born in
non-English speaking countries
Results remained unchanged when excluding those
with unknown country of birth (not shown).
All final competing risk regression models were found
to satisfy proportional hazards assumptions.
Table 2 Competing risk regression models of risk of cancer death, by remoteness, socio-economic disadvantage and country of
birth category, NSW 1980–2008
Unadjusted Model 1a Model 2b Model 3b
Remoteness SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI)
Major cities 1 1 1 1
Inner regional 0.98 (0.97–0.99) 0.97 (0.96–0.98) 1.01 (1.00–1.02) 1.01 (1.00–1.02)
Outer regional/ Remote 1.06 (1.04–1.07) 1.02 (1.01–1.04) 1.04 (1.03–1.06) 1.05 (1.03–1.06)
SEIFA quintile
1 (least disadvantaged) 1 1 1 1
2 1.14 (1.13–1.16) 1.11 (1.10–1.13) 1.05 (1.04–1.07) 1.04 (1.02–1.06)
3 1.26 (1.24–1.28) 1.19 (1.18–1.21) 1.09 (1.07–1.10) 1.08 (1.06–1.09)
4 1.35 (1.33–1.36) 1.26 (1.25–1.28) 1.12 (1.11–1.14) 1.11 (1.09–1.12)
5 (most disadvantaged) 1.46 (1.44–1.47) 1.37 (1.35–1.39) 1.17 (1.16–1.19) 1.15 (1.13–1.17)
Country of birth
Australia 1 1 1 1
Other English speaking 1.14 (1.12–1.15) 1.10 (1.08–1.10) 1.00 (1.00–1.02) 0.99 (0.98–1.01)
Non-English speaking 1.01 (1.00–1.03) 1.09 (1.08–1.10) 0.93 (0.92–0.94) 0.91 (0.90–0.92)
Unknown 0.11 (0.11–0.11) 0.14 (0.13–0.14) 0.20 (0.19–0.21) 0.23 (0.22–0.24)
SEIFA Socio-Economic Index for Areas, SHR Sub-hazard ratio, CI Confidence interval; Country of birth categorised into Australia, other English-speaking and
non-English speaking countries and unknown
aModel 1 adjusted for sex, age, diagnostic period and, as appropriate, for remoteness/SEIFA quintile/country of birth
bModel 2 further adjusted for cancer site and Model 3 further adjusted for summary stage
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Fig. 1 Sub-hazard ratios for socio-economic disadvantage quintiles 2–5 compared with quintile 1 for cases diagnosed in 1980–1989, 1990–1999 and
2000–2008. Sub-hazard ratios with 95% confidence intervals. Socio-economic disadvantage measured as the Index of Relative Socio-Economic
Disadvantage and categorised into quintiles (1: least disadvantaged – 5: most disadvantaged). Models adjusted for sex, age, remoteness,
country of birth, cancer site, and summary stage
Table 3 Competing risk regression models of risk of cancer death by remoteness, socio-economic disadvantage and country of birth




(n = 229, 561)
2000–2008
(n = 264,236)
Site-adjusteda Stage-adjustedb Site-adjusteda Stage-adjustedb Site-adjusteda Stage-adjustedb
Remoteness SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI) SHR (95% CI)
Major cities 1 1 1 1 1 1
Inner regional 0.99 (0.97–1.01) 1.00 (0.98–1.02) 1.01 (0.99–1.03) 1.02 (1.00–1.04) 1.01 (0.99–1.03) 1.02 (1.00–1.04)
Outer regional/ Remote 1.03 (1.00–1.06) 1.04 (1.01–1.07) 1.06 (1.03–1.09) 1.07 (1.04–1.09) 1.03 (1.01–1.06) 1.03 (1.00–1.06)
SEIFA quintile
1 (least disadvantaged) 1 1 1 1 1 1
2 1.01 (0.99–1.04) 1.01 (0.99–1.04) 1.06 (1.04–1.09) 1.04 (1.02–1.07) 1.07 (1.04–1.10) 1.07 (1.04–1.10)
3 1.04 (1.02–1.07) 1.03 (1.01–1.06) 1.08 (1.05–1.10) 1.06 (1.03–1.08) 1.15 (1.12–1.18) 1.14 (1.11–1.17)
4 1.06 (1.04–1.09) 1.05 (1.02–1.08) 1.13 (1.11–1.16) 1.11 (1.08–1.13) 1.17 (1.14–1.20) 1.17 (1.14–1.20)
5 (most disadvantaged) 1.08 (1.06–1.11) 1.07 (1.04–1.10) 1.17 (1.15–1.20) 1.14 (1.12–1.17) 1.25 (1.22–1.28) 1.24 (1.21–1.27)
Country of birth
Australia 1 1 1 1 1 1
Other English speaking 0.99 (0.97–1.01) 0.99 (0.97–1.01) 1.01 (0.99–1.03) 1.00 (0.98–1.02) 1.02 (1.00–1.05) 1.00 (0.98–1.03)
Non-English speaking 0.91 (0.89–0.94) 0.91 (0.88–0.93) 0.93 (0.92–0.95) 0.92 (0.90–0.93) 0.93 (0.91–0.95) 0.90 (0.88–0.92)
Unknown 0.37 (0.35–0.40) 0.40 (0.37–0.43) 0.16 (0.15–0.18) 0.19 (0.17–0.20) 0.17 (0.15–0.18) 0.19 (0.17–0.20)
SEIFA Socio-Economic Index for Areas, SHR Sub-hazard ratio, CI Confidence interval; Country of birth categorised into Australia, other English-speaking and
non-English speaking countries and unknown
aModels adjusted for sex, age, cancer site and, as appropriate, for remoteness/SEIFA quintile/country of birth
bModels further adjusted for summary stage
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Discussion
After accounting for differences in cancer site, summary
stage at diagnosis and death from competing events,
people diagnosed with cancer and living in socio-
economically disadvantaged areas had an overall elevated
risk of cancer death, with an increasing comparative risk
of cancer death over time with increasing socio-
economic disadvantage. Elevated risk of cancer death
was also detected for people with cancer living in outer
regional/remote areas whereas overseas-born people
with cancer had similar/lower risk of cancer death than
Australian-born. Although effect sizes were generally
small, they point to possible areas of disadvantage prob-
ably including pockets of more severe disadvantage than
applying to these areas overall. As in previous studies
reviewed by Quaglia et al. [6], we found socio-economic
cancer survival disparities to remain after adjusting for
summary stage. Similarly, socio-economic survival dis-
parities remained, although diminished, after adjustment
for cancer site illustrating that differences in cancer mix
cannot entirely explain disparities. In addition to poten-
tial residual confounding, factors likely to have contrib-
uted to remaining disparities include differences in
health behaviours, co-morbidities, social support, access
to and quality of treatment and screening services, and
processes for clinical follow-up [1, 6].
Our findings are consistent with the previous inter-
national and Australian literature about cancer survival
disparities [3, 6, 7, 10, 16, 34] and show that these dis-
parities exist after accounting for competing risk events.
Our results are similar to those of studies using cause-
specific survival, which may reflect independence of
competing causes of death [20]. For bias to arise in
cause-specific modelling, competing risks have to be
common compared with the outcome of interest and the
counterfactual risk of the outcome of interest must differ
between those censored and those not censored due to
competing events [35].
In site-specific analyses, we found the strongest socio-
economic survival gradients for liver, melanoma, pros-
tate, lung, colon/rectum, and breast cancer. Previous
Australian studies have reported generally similar find-
ings [7, 10]. Notably, we found a socio-economic sur-
vival gradient for melanoma but not for stomach cancer
in contrast to a recent study from NSW [10]. We used
CD-based SEIFA measures, which may have been more
sensitive in detecting a melanoma survival gradient.
Accounting for competing risks may partly explain the
differences in stomach cancer. Internationally, highest
relative risks have been reported for intermediate or
good prognosis cancers [6]. There may be less potential
for socio-economic factors to impact cancers with over-
all poor prognosis. Our findings in relation to socio-
economic survival gradients for liver and lung cancers
may be explained by differences in risk behaviour and
co-morbidities.
We observed poorer cancer survival with increasing
remoteness for stomach, colon/rectum, cervix and pros-
tate cancers. For colon/rectum, cervix and prostate can-
cers, these findings may partly be explained by access to
and uptake of screening services and other early-detection
initiatives. However, in recent years rural cancer dispar-
ities have been actively addressed by establishing regional
cancer centres and adopting novel approaches, such as tel-
ehealth, to improve rural cancer services in Australia [36].
In addition, differentiating the interconnected effects of
remoteness and socio-economic disadvantage can be chal-
lenging with existing aggregate measures [8].
After adjusting for cancer site and summary stage,
overseas-born people diagnosed with cancer in Australia
generally had similar/lower risk of cancer death than
Australian-born. The extent to which this is artefactual
reflecting loss to follow-up of cases returning to their
country of origin, or a healthy-migrant effect (i.e., migrants
are commonly healthier than general population [37]), is
not known. There is evidence from the United States that
findings of cancer survival advantage among Hispanics and
Asians may be biased due to incomplete follow-up and
missing death information [38]. Under-notification of
country of birth for cancers with a good prognosis
(such as melanoma) is likely to at least partly explain
the relatively low risk of death among people with
unknown country of birth. The NSW CR receives
country of birth information mostly through death
registrations and hospital admission notifications. If
the registry only receives a pathology notification,
country of birth will be missing. Excluding those with
unknown country of birth in a sensitivity analysis had
no impact on results.
When considering the results of both interaction and
period-specific analyses, an increasing comparative risk
of death from cancer was observed over time by socio-
economic disadvantage but not by remoteness or coun-
try of birth. Stanbury et al. reported that socio-economic
cancer disparities for several cancer sites (stomach, colo-
rectal, liver, lung, breast and prostate) remained in NSW
over 1996–2008 [10]. Studies from the UK and New
Zealand have shown that improvements in cancer sur-
vival over time are likely to be slower for more deprived
population groups due to several reasons, including
poorer access to improved treatments, co-morbidities
and stage at diagnosis [13, 14]. Another UK study
highlighted the importance of healthcare related factors
on changes in cancer survival disparities over time [39].
New interventions may be less accessible to deprived
populations leading to increased inequalities [40]. Fur-
ther research is needed on the extent that this applies
to Australia.
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Study limitations
We showed the hazard of cancer death by socio-economic
disadvantage to increase over time in relative terms. Re-
sults based on area-level aggregate measurements are
likely to be biased toward the null and potentially under-
estimate the real extent of survival inequalities, especially
when deprivation measures are based on large geographic
areas [41]. Therefore, we used socio-economic disadvan-
tage measure based on the smallest geographic units avail-
able (CDs). Changes in SEIFA measures over time may
also have impacted our results. However, we conducted
comparative analyses using equal-population quintiles
and, therefore, this impact is likely to be minor. The re-
moteness measure used in this study for 1980–1999 was
based on 2006 SLAs and may not be representative of the
previous 20+ years, which may partly explain why we did
not find changes in survival over time by remoteness.
There is likely to be stage migration over 1980–2008,
but we do not believe that this would have caused a
markedly different impact across the different study
groups. In addition, models were adjusted/stratified by
diagnostic period and stage. We did not have informa-
tion on treatments or co-morbidities which are likely to
influence cancer survival [6]. We were not able to exam-
ine differences in survival for 1980–2008 by Aboriginal
and Torres Strait Islander status, due to under-recording
of Aboriginal status in health registries especially prior
to the late 1990s. Countries of birth were categorised
using broad categories of other English and non-English
speaking countries. Bias due to misclassification of cause
of death being potentially associated with study variables
[35] cannot be completely ruled out.
Conclusions
Active attention is needed to address cancer survival dis-
parities by socio-economic disadvantage, especially as these
disparities appear to have increased. Reasons behind these
disparities should be further examined in order to plan
targeted actions. Collaboration between different stake-
holders, including policy makers, government and health
care providers, is important to ensure comprehensive ap-
proach as disparities are likely to be driven by multiple,
complex processes. A policy emphasis on socio-economic
disadvantage is required if the trend of the widening gap
in death from cancer by socio-economic disadvantage is
to be reversed.
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